Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
17.66
-1.23 (-6.51%)
At close: Jan 30, 2026, 4:00 PM EST
18.01
+0.35 (1.98%)
After-hours: Jan 30, 2026, 7:10 PM EST
Neurogene Market Cap
Neurogene has a market cap or net worth of $273.55 million as of January 30, 2026. Its market cap has increased by 2.93% in one year.
Market Cap
273.55M
Enterprise Value
18.35M
1-Year Change
2.93%
Ranking
Category
Stock Price
$17.66
Market Cap Chart
Since December 19, 2023, Neurogene's market cap has increased from $193.64M to $273.55M, an increase of 41.27%. That is a compound annual growth rate of 17.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 292.60M | -8.30% |
| Dec 31, 2025 | 319.09M | -6.03% |
| Dec 31, 2024 | 339.58M | 36.64% |
| Dec 29, 2023 | 248.52M | 28.34% |
| Dec 19, 2023 | 193.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 312.37M |
| Rezolute | 308.78M |
| Larimar Therapeutics | 304.70M |
| XOMA Royalty | 304.38M |
| Immix Biopharma | 299.84M |
| Atea Pharmaceuticals | 296.10M |
| Cellectis | 295.17M |
| Relmada Therapeutics | 289.67M |